Placebogenomics: A New Concept and Tool for Personalized Medicine and Public Health

Bollyky TJ , and Kickbusch I . (2020). Preparing democracies for pandemics. BMJ, 371, m4088.

Bruen C , and Brugha R . (2014). A ghost in the machine? Politics in global health policy. Int J Health Policy Manag, 3, 1–4.

Canguilhem G . (1989). The Normal and the Pathological. New York: Zone Books.

Carson PE , Flanagan CL , Ickes CE , and Alvong AS . (1956). Enzymatic deficiency in primaquine sensitive erythrocytes. Science, 124, 484–485.

Evangelatos N , Satyamoorthy K , and Brand A . (2018). Personalized health in a public health perspective. Int J Public Health, 63, 433–434.

Hall KT , Lembo AJ , Kirsch I , et al. (2012). Catechol-O-methyltransferase val158-met polymorphism predicts placebo effect in irritable bowel syndrome. PLoS One, 7, e48135.

Hall KT , Loscalzo J , and Kaptchuk TJ . (2015). Genetics and the placebo effect: The placebome. Trends Mol Med, 21, 285–294.

Hofmann B . (2002). On the triad disease, illness and sickness. J Med Philos, 27, 651–673.

Horton R . (1995). Georges Canguilhem: Philosopher of disease. J R Soc Med, 88, 316–319.

Jütte R . (2013). The early history of the placebo. Complement Ther Med, 21, 94–97.

Kalow W . (1962). Pharmacogenetics. Heredity and the Response to Drugs. Philadelphia, PA: W.B. Saunders Co.

Kerr C , Milne I , and Kaptchuk TJ . (2008). William Cullen and a missing mind-body link in the early history of placebos. J R Soc Med, 101, 89–92.

Kickbusch I . (2016). Politics or technocracy—What next for global health?. Int J Health Policy Manag, 5, 201–204.

Levine JD , Gordon NC , and Fields HL . (1978). The mechanisms of placebo analgesia. Lancet, 2, 654–657.

Meletis J . (2012). Favism. A brief history from the “abstain from beans” of Pythagoras to the present. Arch Hellen Med, 29, 258–263.

Motulsky AG . (1957). Drug reactions, enzymes and biochemical genetics. JAMA, 165, 835–837.

Özdemir V , and Endrenyi L . (2021). Rethinking clinical trials and personalized medicine with placebogenomics and placebo dose. OMICS, 25, 1–12.

Petrovic P , Kalso E , Petersson KM , and Ingvar M . (2002). Placebo and opioid analgesia—imaging a shared neuronal network. Science, 295, 1737–1740.

Porter D . (1999). Health, Civilization and the State: A History of Public Health From Ancient to Modern Times. London and New York:. Routledge.

Schedlowski M , Enck P , Rief W , and Bingel U . (2015). Neuro-bio-behavioral mechanisms of placebo and nocebo responses: Implications for clinical trials and clinical practice. Pharmacol Rev, 67, 697–730.

Shi L , Tsai J , and Kao S . (2009). Public health, social determinants of health, and public policy. J Med Sci, 29, 43–59.

Springer S . (2020). Caring geographies: The COVID-19 interregnum and a return to mutual aid. Dialogues Hum Geogr, 10, 112–115.

Vogel F . (1959). Moderne problem der humangenetik. Ergeb Inn Med U Kinderheilk, 12, 52–125.

Wang RS , Hall KT , Giulianini F , Passow D , Kaptchuk TJ , and Loscalzo J . (2017). Network analysis of the genomic basis of the placebo effect. JCI Insight, 2, e93911.